Genetic association studies of antioxidant pathway genes and schizophrenia

Antioxidants and Redox Signaling

Volumn 15, Issue 7, 2011, Pages 2037-2045

  Chowdari, Kodavali V ^a   Bamne, Mikhil N ^a   Nimgaonkar, Vishwajit L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUCOCORTICOID RECEPTOR; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE SYNTHASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; MANGANESE SUPEROXIDE DISMUTASE; METHIONINE SULFOXIDE REDUCTASE; MINERALOCORTICOID RECEPTOR; MITOCHONDRIAL PROTEIN; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANTIOXIDANT ACTIVITY; ENERGY METABOLISM; GENE EXPRESSION; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLUTATHIONE METABOLISM; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CHROMOSOME MAPPING; GENES, MITOCHONDRIAL; GENETIC ASSOCIATION STUDIES; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE SYNTHASE; GLUTATHIONE TRANSFERASE; HUMANS; METHIONINE SULFOXIDE REDUCTASES; NITRIC OXIDE SYNTHASE TYPE I; QUINONE REDUCTASES; RECEPTORS, MINERALOCORTICOID; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE;

EID: 80051964405     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3508     Document Type: Review

References (79)

1. Akyol O, Yanik M, Elyas H, Namli M, Canatan H, Akin H, Yuce H, Yilmaz HR, Tutkun H, Sogut S, Herken H, Ozyurt H, Savas HA, and Zoroglu SS. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29: 123-131, 2005. (Pubitemid 40018214)
2. Al-Chalabi A and Almasy L. Genetics of Complex Human Diseases: a Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 2009.
3. Bamne MN, Mansour H, Monk TH, Buysse DJ, and Nimgaonkar VL. Approaches to unravel the genetics of sleep. Sleep Med Rev DOI information: 10.1016=j.smrv.2010.01.001, 2010.
4. Bamne MN, Talkowski ME, Moraes CT, Manuck SB, Ferrell RE, Chowdari KV, and Nimgaonkar VL. Systematic association studies of mitochondrial DNA variations in schizophrenia: focus on the ND5 gene. Schizophr Bull 34: 458-465, 2008.
5. Butticaz C, Werge T, Beckmann JS, Cuenod M, Do KQ, and Rivolta C. Mutation screening of the glutamate cysteine ligase modifier (GCLM) gene in patients with schizophrenia. Psychiatr Genet 19: 201-208, 2009.
6. Carpenter JWT and Buchanan RW. Medical progress: schizophrenia. N Engl J Med 330: 681-690, 1994.
7. Cheniaux E, Landeira-Fernandez J, Lessa Telles L, Lessa JL, Dias A, Duncan T, and Versiani M. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J Affect Disord 106: 209-217, 2008.
8. Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, Lehner T, Levinson DF, Moran A, Sklar P, and Sullivan PF. Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166: 540-556, 2009.
9. Dlaskova A, Hlavata L, and Jezek P. Oxidative stress caused by blocking of mitochondrial complex I H(\+) pumping as a link in aging=disease vicious cycle. Int J Biochem Cell Biol 40: 1792-1805, 2008.
10. Do KQ, Cabungcal JH, Frank A, Steullet P, and Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19: 220-230, 2009.
11. Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, and Faull RL. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry 5: 85-90, 2000. (Pubitemid 30088457)
12. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, Nestadt G, Liang KY, Huganir RL, Valle D, and Pulver AE. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish caseparent trios. Am J Hum Genet 77: 918-936. Epub 2005 Oct 28, 2005. (Pubitemid 41698514)
13. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 64: 97-112, 1995.
14. Grimaud R, Ezraty B, Mitchell JK, Lafitte D, Briand C, Derrick PJ, and Barras F. Repair of oxidized proteins: identification of a new methionine sulfoxide reductase. J Biol Chem 276: 48915-48920, 2001.
15. Guengerich FP, Thier R, Persmark M, Taylor JB, Pemble SE, and Ketterer B. Conjugation of carcinogens by theta class glutathione S-transferases: mechanisms and relevance to variations in human risk. Pharmacogenetics 5: S103-S107, 1995.
16. Gysin R, Kraftsik R, Sandell J, Bovet P, Chappuis C, Conus P, Deppen P, Preisig M, Ruiz V, Steullet P, Tosic M, Werge T, Cuenod M, and Do KQ. Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA 104: 16621-16626, 2007. (Pubitemid 350211066)
17. Harada S, Tachikawa H, and Kawanishi Y. Glutathione Stransferase M1 gene deletion may be associated with susceptibility to certain forms of schizophrenia. Biochem Biophys Res Commun 281: 267-271, 2001. (Pubitemid 32928147)
18. Harada S, Tachikawa H, and Kawanishi Y. A possible association between an insertion=deletion polymorphism of the NQO2 gene and schizophrenia. Psychiatry Genet 13: 205-209, 2003. (Pubitemid 38033105)
19. Harrison PJ and Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68, 2005. (Pubitemid 40139588)
20. Hayes JD and Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61: 154-166, 2000.
21. Hori H, Ohmori O, Shinkai T, Kojima H, Okano C, Suzuki T, and Nakamura J. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia. Neuropsychopharmacology 23: 170-177, 2000. (Pubitemid 30406901)
22. Jablensky A. The epidemiology of schizophrenia. Curr Opin Psychiatry 6: 43-52, 1993. (Pubitemid 23088777)
23. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 250: 274-285, 2000. (Pubitemid 32002381)
24. Jablensky AV and Kalaydjieva LV. Genetic epidemiology of schizophrenia: phenotypes, risk factors, and reproductive behavior. Am J Psychiatry 160: 425-429, 2003.
25. Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Inada T, Harano M, Komiyama T, Hori T, Yamada M, Iyo M, Sora I, Sekine Y, Ozaki N, Ujike H, and Iwata N. Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population. Ann N Y Acad Sci 1139: 63-69, 2008.
26. Kucukali CI, Aydin M, Ozkok E, Orhan N, Cakir U, Kilic G, Ozbek Z, Ince N, and Kara I. Paraoxonase-1 55=192 genotypes in schizophrenic patients and their relatives in the Turkish population. Psychiatry Genet 18: 289-294, 2008.
27. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, Kucherlapati R, and Malhotra AK. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12: 572-580, 2007. (Pubitemid 46816774)
28. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, and Helgason T. Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73: 34-48, 2003. (Pubitemid 36793778)
29. Liou YJ, Tsai SJ, Hong CJ, and Liao DL. Association analysis for the CA repeat polymorphism of the neuronal nitric oxide synthase (NOS1) gene and schizophrenia. Schizophr Res 65: 57-59, 2003.
30. Ma J, Li DM, Zhang R, Yang XD, Gao CG, Lu SM, Wu SN, and Wang L. Genetic analysis of glutamate cysteine ligase modifier (GCLM) gene and schizophrenia in Han Chinese. Schizophr Res 119: 273-274, 2010.
31. Mah S, Nelson MR, Delisi LE, Reneland RH, Markward N, James MR, Nyholt DR, Hayward N, Handoko H, Mowry B, Kammerer S, and Braun A. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol Psychiatry 11: 471-478, 2006.
32. Malhi GS, Green M, Fagiolini A, Peselow ED, and Kumari V. Schizoaffective disorder: diagnostic issues and future recommendations. Bipolar Disord 10: 215-230, 2008.
33. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, and Visscher PM. Finding the missing heritability of complex diseases. Nature 461: 747-753, 2009.
34. Marchbanks RM, Ryan M, Day IN, Owen M, McGuffin P, and Whatley SA. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 65: 33-38, 2003. (Pubitemid 37410401)
35. Matsumoto C, Ohmori O, Hori H, Shinkai T, and Nakamura J. Analysis of association between the Gln192Arg polymorphism of the paraoxonase gene and schizophrenia in humans. Neurosci Lett 321: 165-168, 2002. (Pubitemid 34203825)
36. Matsuzawa D, Hashimoto K, Hashimoto T, Shimizu E, Watanabe H, Fujita Y, and Iyo M. Association study between the genetic polymorphisms of glutathione-related enzymes and schizophrenia in a Japanese population. Am J Med Genet B Neuropsychiatr Genet 150B: 86-94, 2009.
37. McGue M, Gottesman II, and Rao DC. The transmission of schizophrenia under a multifactorial threshold model. Am J Hum Genet 35: 1161-1178, 1983. (Pubitemid 14201169)
38. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, Jamra RA, Albus M, Bacanu S-A, Baron M, Barrett TB, Berrettini B, Blacker D, Byerley W, Cichon S, Coryell W, Craddock N, Daly M, DePaulo JR, Edenberg HJ, Foroud T, Gill M, Gilliam C, Hamshere M, Jones I, Jones L, Juo SH, Kelsoe JR, Lambert D, Lange C, Lerer B, Liu J, Maier W, MacKinnon JD, McInnis MG, McMahon FJ, Murphy DL, Nothen MM, Nurnberger JI, Pato CN, Pato MT, Potash JB, Propping P, Pulver AE, Rice JP, Rietschel M, Scheftner W, Schumacher J, Segurado R, Van Steen K, Xie W, Zandi P, and Laird NM. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence for susceptibility loci on chromosomes 6q and 8 q. Am J Hum Genet 77: 582-595, 2005. (Pubitemid 41361605)
39. Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, and O'Donovan MC. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14: 252-260, 2009.
40. Need AC, Ge D, Weale ME, Maia J, Feng S, Heinzen EL, Shianna KV, Yoon W, Kasperaviciute D, Gennarelli M, Strittmatter WJ, Bonvicini C, Rossi G, Jayathilake K, Cola PA, McEvoy JP, Keefe RS, Fisher EM, St Jean PL, Giegling I, Hartmann AM, Moller HJ, Ruppert A, Fraser G, Crombie C, Middleton LT, St Clair D, Roses AD, Muglia P, Francks C, Rujescu D, Meltzer HY, and Goldstein DB. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5: e1000373, 2009.
41. Nimgaonkar VL, Fujiwara TM, Dutta M, Wood J, Gentry K, Maendel S, Morgan K, and Eaton J. Low prevalence of psychoses among the Hutterites, an isolated religious community. Am J Psychiatry 157: 1065-1070, 2000. (Pubitemid 30432485)
42. Norton N, Williams HJ, and Owen MJ. An update on the genetics of schizophrenia. Curr Opin Psychiatry 19: 158-164, 2006. (Pubitemid 44406127)
43. O'Donovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, Nikolov I, Hamshere M, Carroll L, Georgieva L, Dwyer S, Holmans P, Marchini JL, Spencer CC, Howie B, Leung HT, Hartmann AM, Moller HJ, Morris DW, Shi Y, Feng G, Hoffmann P, Propping P, Vasilescu C, Maier W, Rietschel M, Zammit S, Schumacher J, Quinn EM, Schulze TG, Williams NM, Giegling I, Iwata N, Ikeda M, Darvasi A, Shifman S, He L, Duan J, Sanders AR, Levinson DF, Gejman PV, Cichon S, Nothen MM, Gill M, Corvin A, Rujescu D, Kirov G, Owen MJ, Buccola NG, Mowry BJ, Freedman R, Amin F, Black DW, Silverman JM, Byerley WF, and Cloninger CR. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40: 1053-1055, 2008.
44. Okumura T, Okochi T, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Tsunoka T, Ujike H, Inada T, Ozaki N, and Iwata N. No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population. Neuromol Med 11: 123-127, 2009.
45. Owen MJ, Craddock N, and O'Donovan MC. Schizophrenia: genes at last? Trends Genet 21: 518-525, 2005. (Pubitemid 41132587)
46. Pae CU, Kim JJ, Lee SJ, Lee CU, Lee C, Paik IH, Park HR, Yang S, and Serretti A. Association study between glutathione S-transferase P1 polymorphism and schizophrenia in the Korean population. Prog Neuropsychopharmacol Biol Psychiatry 27: 519-523, 2003. (Pubitemid 36403744)
47. Pae CU, Kim TS, Patkar AA, Kim JJ, Lee CU, Lee SJ, Jun TY, Lee C, and Paik IH. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia. Psychiatry Res 153: 77-81, 2007. (Pubitemid 47374823)
48. Petronis A. The genes for major psychosis: aberrant sequence or regulation? Neuropsychopharmacology 23: 1-12, 2000. (Pubitemid 30408307)
49. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, and Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9: 643, 684-697, 2004. (Pubitemid 38932169)
50. Prasad KM, Talkowski ME, Chowdari KV, McClain L, Yolken RH, and Nimgaonkar VL. Candidate genes and their interactions with other genetic=environmental risk factors in the etiology of schizophrenia. Brain Res Bull 83: 86-92, 2010.
51. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, and Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460: 748-752, 2009.
52. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, and Mahadik SP. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121: 109-122, 2003. (Pubitemid 37500981)
53. Reddy R, Sahebarao MP, Mukherjee S, and Murthy JN. Enzymes of the antioxidant defense system in chronic schizophrenic patients. Biol Psychiatry 30: 409-412, 1991.
54. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Topner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, and Lesch KP. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11: 286-300, 2006.
55. Risch N. Linkage strategies for genetically complex traits, I: multilocus models. Am J Hum Genet 46: 222-228, 1990.
56. Rodriguez-Santiago B, Brunet A, Sobrino B, Serra-Juhe C, Flores R, Armengol L, Vilella E, Gabau E, Guitart M, Guillamat R, Martorell L, Valero J, Gutierrez-Zotes A, Labad A, Carracedo A, Estivill X, and Perez-Jurado LA. Association of common copy number variants at the glutathione Stransferase genes and rare novel genomic changes with schizophrenia. Mol Psychiatry 15: 1023-1033, 2010.
57. Saadat M, Mobayen F, and Farrashbandi H. Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia. Psychiatry Res 153: 87-91, 2007. (Pubitemid 47374820)
58. Schulz JB, Lindenau J, Seyfried J, and Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267: 4904-4911, 2000. (Pubitemid 30641286)
59. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, and Gejman PV. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460: 753-757, 2009.
60. Shinkai T, Ohmori O, Hori H, and Nakamura J. Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7: 560-563, 2002.
61. Shirts BH and Nimgaonkar V. The genes for schizophrenia: finally a breakthrough? Curr Psychiatry Rep 6: 303-312, 2004. (Pubitemid 39173547)
62. Spielman RS and Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission=disequilibrium test. Am J Hum Genet 62: 450-458, 1998. (Pubitemid 28110787)
63. Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I, and Brinkmann U. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics 10: 557-565, 2000.
64. Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyl JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Gollmbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, and Collier DA. Common variants conferring risk of schizophrenia. Nature 460: 744-747, 2009.
65. Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, and Lieberman JA. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29: 15-31, 2003. (Pubitemid 36871054)
66. Sullivan PF. Schizophrenia genetics: the search for a hard lead. Curr Opin Psychiatry 21: 157-160, 2008. (Pubitemid 351339870)
67. Talkowski ME, Bamne M, Mansour H, and Nimgaonkar VL. Dopamine genes and schizophrenia: case closed or evidence pending? Schizophr Bull 33: 1071-1081, 2007. (Pubitemid 47347918)
68. Tang W, Huang K, Tang R, Zhou G, Fang C, Zhang J, Du L, Feng G, He L, and Shi Y. Evidence for association between the 5' flank of the NOS1 gene and schizophrenia in the Chinese population. Int J Neuropsychopharmacol 11: 1063-1071, 2008.
69. Taurines R, Thome J, Duvigneau JC, Forbes-Robertson S, Yang L, Klampfl K, Romanos J, Muller S, Gerlach M, and Mehler-Wex C. Expression analyses of the mitochondrial complex I 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: increased levels as a potential biomarker for early onset schizophrenia. Eur Child Adolesc Psychiatry 19: 441-448, 2010.
70. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F, Matthey ML, Parnas J, Preisig M, Saraga M, Solida A, Timm S, Wang AG, Werge T, Cuenod M, and Do KQ. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79: 586-592, 2006. (Pubitemid 44384270)
71. Tsuang MT and Faraone SV. The genetic epidemiology of bipolar disorder. In: Bipolar Disorders: 100 Years after Manicdepressive Insanity, edited by Marneros A, Angst J. Zurich: Kluwer Academic, 2000, p. 508.
72. Ventriglia M, Scassellati C, Bonvicini C, Squitti R, Bevacqua MG, Foresti G, Tura GB, and Gennarelli M. No association between Ala9Val functional polymorphism of MnSOD gene and schizophrenia in a representative Italian sample. Neurosci Lett 410: 208-211, 2006. (Pubitemid 44750349)
73. Vincent SR. Nitric oxide: a radical neurotransmitter in the central nervous system. Prog Neurobiol 42: 129-160, 1994. (Pubitemid 24026121)
74. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, and Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539-543, 2008. (Pubitemid 351590668)
75. Walss-Bass C, Soto-Bernardini MC, Johnson-Pais T, Leach RJ, Ontiveros A, Nicolini H, Mendoza R, Jerez A, Dassori A, Chavarria-Siles I, Escamilla MA, and Raventos H. Methionine sulfoxide reductase: a novel schizophrenia candidate gene. Am J Med Genet B Neuropsychiatr Genet 150B: 219-225, 2009.
76. Webster MJ, Knable MB, O'Grady J, Orthmann J, and Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 7: 924, 985-994, 2002.
77. Whatley SA, Curti D, and Marchbanks RM. Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res 21: 995-1004, 1996. (Pubitemid 26349764)
78. Xing GQ, Russell S, Webster MJ, and Post RM. Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder. Int J Neuropsychopharmacol 7: 143-153, 2004. (Pubitemid 38823281)
79. Yao JK, Leonard S, and Reddy R. Altered glutathione redox state in schizophrenia. Dis Markers 22: 83-93, 2006. (Pubitemid 41831607)